Nantahala Capital Management - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,873,662
-46.9%
341,081
-33.1%
0.93%
-53.1%
Q2 2023$20,470,143
-36.5%
509,461
-32.5%
1.98%
-19.8%
Q1 2023$32,243,581
-19.5%
755,119
-9.5%
2.47%
-4.8%
Q4 2022$40,048,344
+19.9%
833,993
-6.0%
2.60%
+20.1%
Q3 2022$33,391,000
+26.7%
887,592
-6.9%
2.16%
+63.6%
Q2 2022$26,354,000
-43.6%
953,801
+11.1%
1.32%
-36.1%
Q1 2022$46,698,000
-4.6%
858,730
+2.7%
2.07%
+20.0%
Q4 2021$48,938,000
+62.7%
836,398
+10.0%
1.72%
+81.6%
Q3 2021$30,081,000
+18.3%
760,383
+27.0%
0.95%
+31.1%
Q2 2021$25,434,000
-10.2%
598,880
+30.1%
0.72%
-12.7%
Q1 2021$28,336,000
-24.8%
460,372
-13.9%
0.83%
-29.1%
Q4 2020$37,705,000
+253.1%
534,514
+93.1%
1.17%
+257.2%
Q3 2020$10,677,000
+3.5%
276,827
+0.7%
0.33%
+5.1%
Q2 2020$10,315,000275,0000.31%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 321,300$12,087,0004.99%
First Light Asset Management, LLC 598,213$22,505,0002.28%
Nantahala Capital Management 845,692$31,815,0002.06%
CHI Advisors LLC 200,229$7,533,0002.03%
Fairmount Funds Management LLC 272,498$10,251,0001.80%
Altium Capital Management LP 88,000$3,311,0001.21%
Orbimed Advisors 1,679,417$63,180,0001.17%
SPHERA FUNDS MANAGEMENT LTD. 206,819$7,781,0001.08%
Parkman Healthcare Partners LLC 99,927$3,759,0001.07%
Soleus Capital Management, L.P. 146,000$5,493,0000.75%
View complete list of KEROS THERAPEUTICS INC shareholders